Overview

* Definitive Healthcare ( DH ) Q3 revenue declines 4% yr/yr but slightly beats analyst expectations

* Net loss for Q3 reduced significantly from prior year due to goodwill impairment charges

* Adjusted EBITDA for Q3 exceeds expectations by $2 mln

Outlook

* Company expects Q4 revenue between $59.0 mln and $60.0 mln

* Definitive Healthcare ( DH ) raises bottom end of FY revenue forecast by $2.0 mln

* Company sees FY adjusted EBITDA between $68.0 mln and $69.0 mln

Result Drivers

* CUSTOMER WINS - Co reports new customer acquisitions and expansion opportunities across all end-markets, driven by data and integration capabilities

* STRATEGIC INITIATIVES - CEO Kevin Coop cites progress in new logo production and retention rates as key drivers of Q3 performance

* COMPETITIVE DISPLACEMENTS - Co secured competitive displacements by providing critical insights and data integration, enhancing customer value

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Slight $60.05 $59.50

Revenue Beat* mln mln (12

Analysts

)

Q3 Net -$17.79

Income mln

Q3 Gross $45.99

Profit mln

Q3 -$17.27

Pretax mln

Profit

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy."

* Wall Street's median 12-month price target for Definitive Healthcare Corp ( DH ) is $4.50, about 39.6% above its November 5 closing price of $2.72

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)